Sue Beaudin
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
FeNO as a Treatable Trait in Chronic Cough: Insights from the PROCOUGH Study.
Journal: Lung
Published: June 12, 2026
Moving Beyond Responders: A Post Hoc Analysis Identifying Criteria for Chronic Cough Control.
Journal: Chest
Published: March 31, 2026
Prospective study to evaluate the effectiveness of guideline-based therapy for chronic cough and refractory chronic cough: PROCOUGH.
Journal: ERJ open research
Published: February 18, 2026
Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.
Journal: The European respiratory journal
Published: January 19, 2026
Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial.
Journal: The European respiratory journal
Published: July 28, 2025
Effect of benralizumab on inflammation in skin after intradermal allergen challenge in patients with moderate-to-severe atopic dermatitis.
Journal: The journal of allergy and clinical immunology. Global
Published: February 14, 2024
Inhibition of allergen-induced basophil activation by ASM-024, a nicotinic receptor ligand.
Journal: International archives of allergy and immunology
Published: July 08, 2014
IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma.
Journal: International archives of allergy and immunology
Published: May 11, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026